Skip to search formSkip to main contentSkip to account menu

Osteoporosis

Known as: OSTEOPOROSE, Osteoporosis [Disease/Finding], Osteoporoses 
A condition of reduced bone mass, with decreased cortical thickness and a decrease in the number and size of the trabeculae of cancellous bone (but… 
National Institutes of Health

Related topics

Related topics

50 relations
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2Bone Demineralization, PathologicBruck syndrome 1CALCA gene

Broader (1)

Metabolic Bone Disorder

Narrower (5)

Osteoporosis, PostmenopausalOsteoporotic FracturesTRANSIENT REGIONAL OSTEOPOROSISWinchester syndrome (disorder)

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
The clinical epidemiology of male osteoporosis: a review of the recent literature
Osteoporosis, a musculoskeletal disease characterized by decreased bone mineral density (BMD) and an increased risk of fragility… 
Highly Cited
2007
Highly Cited
2007
Effects Of a One‐Month Treatment With PTH(1–34) on Bone Formation on Cancellous, Endocortical, and Periosteal Surfaces of the Human Ilium
Using bone histomorphometry, we found that a 1‐month treatment with PTH(1–34) [hPTH(1–34)] stimulated new bone formation on… 
Review
2004
Review
2004
LRP5 and Wnt Signaling: A Union Made for Bone
THE IDENTIFICATION OF mutations in the human lowdensity lipoprotein (LDL) receptor–related protein 5 (LRP5) gene that give rise… 
Highly Cited
2003
Highly Cited
2003
Low frequency of treatment of osteoporosis among postmenopausal women following a fracture.
BACKGROUND Osteoporosis is a major cause of morbidity. Treatment of osteoporosis reduces the risk of fracture, particularly for… 
Highly Cited
2001
Highly Cited
2001
Comparison of the Short-Term Biological Effects of 7α-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)-nonyl]estra-1,3,5, (10)-triene-3,17β-diol (Faslodex) versus Tamoxifen in Postmenopausal Women with…
7Alpha-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)-nonyl]estra-1,3,5, (10)-triene-3,17beta-diol (ICI 182,780; Faslodex) is a novel… 
Highly Cited
2001
Highly Cited
2001
Design and methods of the Raloxifene Use for The Heart (RUTH) study.
Review
2000
Review
2000
Metal-bone interactions.
Review
1995
Review
1995
Reviews and Notes: Assessment of Fracture Risk and Its Application to Screening for Postmenopausal Osteoporosis
Assessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis 129 pages. Geneva: World Health… 
Highly Cited
1989
Highly Cited
1989
'Calcium-activated' intracellular calcium elevation: a novel mechanism of osteoclast regulation.
Highly Cited
1986
Highly Cited
1986
A new method for the two‐dimensional analysis of bone structure in human iliac crest biopsies
A new method is described for the analysis of the two‐dimensional structural pattern of trabecular bone in human iliac crest… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)